07-1398 | Anti-phospho-Akt (Thr308) Antibody

07-1398
100 µL  
Retrieving price...
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Click To Print This Page

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, M, R, B, Xn, CaIH(P)RbAffinity PurifiedPolyclonal Antibody
      Description
      Catalogue Number07-1398
      DescriptionAnti-phospho-Akt (Thr308) Antibody
      Alternate Names
      • Protein kinase B
      • RAC-alpha serine/threonine-protein kinase
      • murine thymoma viral (v-akt) oncogene homolog-1
      • rac protein kinase alpha
      • v-akt murine thymoma viral oncogene homolog 1
      Background InformationAkt/PKB is a Ser/Thr kinase and a major known effecter of the PI3 Kinase pathway. It is involved in multiple signaling pathways that relate to many biological processes including metabolism, apoptosis, cell cycle control, angiogenesis, differentiation, and cell growth and proliferation. In mammals, three isoforms of Akt (Akt1/PKCα, Akt2/PKBβ, and Akt3/PKBγ) exists. They exhibit a high degree of homology, but differ slightly in the localization of their regulatory phosphorylation sites. Akt1 is the predominant isoform that is in most tissues and is thought to have a dominant role in growth, survival, embryonic development, and adipocyte differentiation. Akt2 is correlated with the regulation of glucose homeostasis and is the predominant isoform expressed in insulin-responsive tissues. Akt3 is abundant in brain tissue. Each Akt isoform is composed of three functionally distinct regions: an N-terminal Pleckstrin Homology (PH) domain that provides a lipid-binding module, a central catalytic domain containing Thr308, and a C-terminal hydrophobic motif containing Ser473. The activation of AKT is dependent on a dual regulatory mechanism that requires both its translocation to the plasma membrane and dual phosphorylation on Thr308 and Ser473 by PDK1 and the TORC2 complex, respectively.
      References
      Product Information
      FormatAffinity Purified
      PresentationAntigen affinity purified rabbit serum in 0.1M Tris-Glycine (pH7.4), 150mM NaCl, with 0.05% NaN3.
      Applications
      ApplicationThis Anti-phospho-Akt (Thr308) Antibody is validated for use in IH(P) for the detection of phospho-Akt (Thr308).
      Key Applications
      • Immunohistochemistry (Paraffin)
      Applications Not Recommended
      • Western Blotting
      Application NotesImmunohistochemistry only

      Western Blot Analysis:
      Not recommended for WB as it gives multiple bands. Please refer to 05-802R
      Biological Information
      ImmunogenKLH-conjugated synthetic peptide containing the Thr308 sequence and surrounding amino acids of human, mouse, rat, bovine and chicken Akt1. Human and mouse Akt2 shares 11/12 amino acids and rat Akt3 shares 10/12 amino acids with the peptide immunogen sequence.
      EpitopeThr308 (Catalytic Domain)
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostRabbit
      SpecificityDetects Akt only when phosphorylated on Thr308.
      IsotypeIgG
      Species Reactivity
      • Human
      • Mouse
      • Rat
      • Bovine
      • Xenopus
      • Canine
      Species Reactivity NoteMouse tested. Expected to react with Human, Rat, Chicken, Dog, Xenopus, and Cow based on 100% immunogen sequence homology.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThe serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq].

      Transcript Variant: This variant (3) lacks the 5' exon, but has a upstream alternate 5' exon, as compared to variant 1. Variants 1 and 3 encode the same protein.
      Gene Symbol
      • AKT
      • C-AKT
      • EC 2.7.11.1
      • MGC99656
      • PKB
      • PKB-ALPHA
      • RAC
      • RAC-ALPHA
      • RAC-PK-alpha
      Modifications
      • Phosphorylation
      Purification MethodAntigen affinity purified against both the phosphorylated and the non-phosphorylated peptides of Akt (Thr308).
      UniProt Number
      UniProt SummaryFUNCTION: General protein kinase capable of phosphorylating several known proteins. Phosphorylates TBC1D4. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). Plays a role in glucose transport by mediating insulin-induced translocation of the GLUT4 glucose transporter to the cell surface. Mediates the antiapoptotic effects of IGF-I. Mediates insulin-stimulated protein synthesis, partly by playing a role in both insulin-induced phosphorylation of 4E-BP1 and in insulin-induced activation of p70 S6 kinase. Promotes glycogen synthesis by mediating the insulin-induced activation of glycogen synthase. Ref.4 Ref.8 Ref.12 Ref.13 Ref.16 Ref.20

      Catalytic activity ATP + a protein = ADP + a phosphoprotein. Ref.4 Ref.20 Ref.1

      ENZYME REGULATION:Three specific sites, one in the kinase domain (Thr-308) and the two other ones in the C-terminal regulatory region (Ser-473 and Tyr-474), need to be phosphorylated for its full activation. Ref.8 Ref.6

      SUBUNIT STRUCTURE: Interacts with AGAP2 isoform 2 (PIKE-A) in the presence of guanine nucleotides. The C-terminus interacts with CCDC88A/GRDN and THEM4. Interacts with AKTIP. Interacts (via PH domain) with MTCP1, TCL1A AND TCL1B. Interacts with CDKN1B; the interaction phosphorylates CDKN1B promoting 14-3-3 binding and cell-cycle progression. Ref.13 Ref.16 Ref.20 Ref.9 Ref.10 Ref.11 Ref.15 Ref.17 Ref.18 Ref.19

      SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell membrane. Note= Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Ref.11

      TISSUE SPECIFICITY: In all human cell types so far analyzed. Ref.4

      DOMAIN: Binding of the PH domain to the phosphatidylinositol 3-kinase alpha (PI(3)K) results in its targeting to the plasma membrane.

      The AGC-kinase C-terminal mediates interaction with THEM4.

      PTM: Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Ser-473 phosphorylation by the Rictor-mTor complex favors Thr-308 phosphorylation by PDPK1. Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is enhanced in focal cortical dysplasias with Taylor-type balloon cells.

      SIMILARITY:Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. RAC subfamily.

      Contains 1 AGC-kinase C-terminal domain.

      Contains 1 PH domain.

      Contains 1 protein kinase domain.

      Molecular Weight60 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceImmunohistochemistry Analysis:
      Antibody diluted to 1:500, IHC-Select Detection with HRP-DAB.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      SDS

      Title

      Safety Data Sheet (SDS) 

      Certificates of Analysis

      TitleLot Number
      Anti-phospho-Akt (Thr308) (IHC only) - 2147123 2147123
      Anti-phospho-Akt (Thr308) (IHC only) - 2433378 2433378
      Anti-phospho-Akt (Thr308) (IHC only) - 2073644 2073644
      Anti-phospho-Akt (Thr308) (IHC only) - 2298423 2298423
      Anti-phospho-Akt (Thr308) (IHC only) - NG1593355 NG1593355
      Anti-phospho-Akt (Thr308) (IHC only) - NG1667752 NG1667752
      Anti-phospho-Akt (Thr308) (IHC only) - NG1755187 NG1755187
      Anti-phospho-Akt (Thr308) (IHC only) -2488833 2488833
      Anti-phospho-Akt (Thr308) (IHC only) -2524675 2524675
      Anti-phospho-Akt (Thr308) (IHC only) -2575908 2575908